Scientists don’t yet fully understand how GLP-1 drugs like Ozempic affect the brain’s reward pathways, but there are ...

Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

A new study shows that popular weight‑loss drugs may help the heart after a person has a heart attack. These drugs are already used to help people lose weight or treat diabetes. Now researchers think ...

Stimulant medications can make some people have a smaller appetite. If you take both a GLP⁠-1 and a stimulant, you might not feel the need to eat as much as you need to. That could cause you to lose ...

A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose some weight. Reading time 5 minutes The arrival of semaglutide and similar ...

It's yet another perk of these medications.

A coalition of Hispanic health and public policy organizations is pushing for New Mexico’s Medicaid program to broaden its coverage of weight loss drugs as treatment for obesity. The policy change, ...